Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor

NCT03512119 · clinicaltrials.gov ↗

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis Homozygous for Phe 508 Del CFTR
Glucose Intolerance or Newly Diagnosis Diabetes

Interventions

DRUG: Lumacaftor-Ivacaftor treatment

Sponsor

University Hospital, Strasbourg, France